• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE - HAYWARD FLOSEAL HEMOSTATIC MATRIX; AGENT, ABSORBABLE HEMOSTATIC, COLLAGEN BASED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE - HAYWARD FLOSEAL HEMOSTATIC MATRIX; AGENT, ABSORBABLE HEMOSTATIC, COLLAGEN BASED Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problem Unspecified Infection (1930)
Event Date 05/01/2014
Event Type  Injury  
Event Description
Study title: (b)(4).This is an investigator initiated study (iis) case supported by baxter.Between (b)(6) 2009 and (b)(6) 2011,103 total shoulder replacements were performed by a single surgeon with the use of the hemostatic agent, floseal.All patients were initially evaluated with a history, active range of motion (rom), and radiographic measurements including antero-posterior (ap) and axillary (ax) radiographs.One patient developed a post-operative infection and required arthroscopic débridement, distal clavicle resection, and suprascapular nerve decompression.No sample available.
 
Event Description
(b)(4).Baxter medical science liaison spoke with dr.(b)(6) research coordinator ((b)(6)) and she said that dr.(b)(6) stated that the infection that she ((b)(6)had written the first draft that was provided to baxter) had included in the draft manuscript was not a procedure-related infection.Apparently when they were in surgery and got down to the surgical site they identified what looked to be an infection, they cultured it, and post operatively the culture came back positive.This identification of a possible infection was made prior to floseal having been used.Therefore, he said that this was unrelated to floseal use, as he suspected this infection to be present prior to use, as he identified it during surgery.
 
Manufacturer Narrative
(b)(4).Baxter medical assessment: postoperative infection is a rare, but yet expected complication after surgical procedures.Given the limited clinical information (mention of adverse event in a clinical publication), and the inability for further clinical investigation, we cannot exclude that floseal has contributed to the reported postoperative complication.A follow-up report will be submitted upon receipt and completion of the manufacturer's investigation.
 
Manufacturer Narrative
(b)(4).Baxter hayward completed the investigation.Sample evaluation and batch review could not be performed as no sample or lot number was provided.Floseal¿s instructions for use (ifu) was reviewed and it was found to be adequate and sufficient.No trend was identified.Per hayward, no further investigation is required.This case will be kept on file for trending purposes.
 
Manufacturer Narrative
(b)(4).Additional case information was received on (b)(4) 2014 and the case was re-assessed by baxter's medical director.Baxter final medical assessment: based on the additional clinical information received the reported infection has been detected during the surgical procedure and before the application of floseal.Therefore, the reported postoperative infection is not related to the use of floseal.As the case was determined to be not related to the use of floseal, no further action is necessary.This case will be kept on file for trending purposes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLOSEAL HEMOSTATIC MATRIX
Type of Device
AGENT, ABSORBABLE HEMOSTATIC, COLLAGEN BASED
Manufacturer (Section D)
BAXTER HEALTHCARE - HAYWARD
2024 w winton ave
hayward CA 94545
Manufacturer (Section G)
BAXTER HEALTHCARE - HAYWARD
2024 w winton ave
hayward CA 94545
Manufacturer Contact
kimberly crane
one baxter way
westlake village, CA 91362
8053723182
MDR Report Key3801016
MDR Text Key4525117
Report Number2032282-2014-00069
Device Sequence Number1
Product Code LMF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P990009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 05/01/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/08/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/11/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-